Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.34% | -35.14% | -29.45% | -38.91% | -41.07% |
| Total Depreciation and Amortization | 1.22% | -3.06% | -2.95% | -0.20% | 3.45% |
| Total Amortization of Deferred Charges | -5.58% | 5.19% | 5.19% | 5.19% | 5.19% |
| Total Other Non-Cash Items | 216.74% | 954.27% | 752.21% | 492.86% | 161.58% |
| Change in Net Operating Assets | 214.18% | -88.69% | 87.47% | 100.15% | 88.84% |
| Cash from Operations | -3.82% | -13.70% | 10.23% | 17.77% | 17.53% |
| Capital Expenditure | 50.69% | 20.87% | 1.22% | -38.26% | -64.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | 98.03% | -67.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.41% | -107.90% | 98.35% | 95.37% | 120.52% |
| Cash from Investing | 82.67% | 77.69% | 87.73% | 82.35% | 23.57% |
| Total Debt Issued | -53.78% | -83.11% | -100.00% | -80.30% | -63.69% |
| Total Debt Repaid | 69.92% | 52.91% | 0.68% | -32.55% | 51.30% |
| Issuance of Common Stock | -15.09% | 47.47% | 121.21% | 122.10% | 104.39% |
| Repurchase of Common Stock | -176.95% | -79.58% | 26.86% | -177.18% | -110.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.06% | -0.48% | -0.47% | -0.12% | -0.27% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -107.44% | -158.36% | -278.12% | -263.17% | -641.20% |
| Foreign Exchange rate Adjustments | 611.23% | 144.03% | 163.43% | 7,649.34% | 30.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.12% | -94.02% | 237.24% | 334.28% | -459.57% |